Alzinova AB
ALZ | ST
Overview
Corporate Details
- ISIN(s):
- SE0007413455
- LEI:
- 549300K3IMVT20EK2S13
- Country:
- Sweden
- Address:
- Pepparedsleden 1, 431 83 MÖLNDAL
- Website:
- https://www.alzinova.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Alzinova AB is a clinical-stage biopharmaceutical company specializing in the development of disease-modifying treatments for Alzheimer's disease. The company pioneers active and passive immunotherapies utilizing its proprietary AβCC Peptide™ technology platform. This approach specifically targets neurotoxic amyloid-beta (Aβ) oligomers, a key driver of the disease. Alzinova's lead candidate, ALZ-101, is a therapeutic vaccine in clinical development. The company's long-term goal is to develop a vaccine for both the treatment and prevention of Alzheimer's disease progression.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Alzinova AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Alzinova AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Alzinova AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-03 | Tord Evert Sigfried Labuda | Other | Other | 1,000,000 | 260,000.00 SEK |
| 2025-04-03 | Tord Evert Sigfried Labuda | Other | Buy | 10,000 | 18,800.00 SEK |
| 2025-04-02 | Tord Evert Sigfried Labuda | Other | Buy | 20,000 | 40,000.00 SEK |
| 2024-12-16 | Erik Kullgren | Other | Buy | 10,000 | 34,400.00 SEK |
